Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 HKD | +3.66% | +5.88% | -10.41% |
30/04 | Chaoju Eye Care Unit Buys Structured Deposits Worth 150 Million Yuan | MT |
16/04 | Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 65% by 2026.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.41% | 342M | - | ||
-18.46% | 16.57B | B+ | ||
+4.50% | 12.51B | B | ||
+4.31% | 11.69B | B+ | ||
+5.36% | 10.36B | B+ | ||
+24.72% | 8.38B | B | ||
-2.64% | 7.75B | A- | ||
+19.32% | 7.16B | D | ||
+4.17% | 6.6B | B- | ||
+46.90% | 4.54B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2219 Stock
- Ratings Chaoju Eye Care Holdings Limited